These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37633165)

  • 1. Investigating Betrixaban Maleate drug degradation profiles, isolation and characterization of unknown degradation products by mass-triggered preparative HPLC, HRMS, and NMR.
    Surukonti SR; Manabolu Surya SB; Katari NK; Yerla RR
    J Pharm Biomed Anal; 2023 Oct; 235():115643. PubMed ID: 37633165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of pseudo degradation products of acalabrutinib using ESI-HRMS/MS and NMR: Formation of possible geometrical isomers.
    Panda S; Das M; Kandula RR; Gajjela R; Ravuri NDH; Kumar H; Kalamse S; Mathur A; Roy A; Bagadi M
    J Pharm Biomed Anal; 2023 Feb; 225():115214. PubMed ID: 36621281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
    Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
    Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
    J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress degradation study on entrectinib and characterization of its degradation products using HRMS and NMR.
    Dhiman V; Singh S; Balhara A; Kushwah BS; Velip L; Golla VM; Samanthula G
    J Pharm Biomed Anal; 2022 Jan; 208():114459. PubMed ID: 34768159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive study to identify and characterize major degradation products of Ivermectin drug substance including its degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 May; 214():114730. PubMed ID: 35334396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation studies of lansoprazole using LC-ESI HRMS and
    Shankar G; Borkar RM; Suresh U; Guntuku L; Naidu VGM; Nagesh N; Srinivas R
    J Mass Spectrom; 2017 Jul; 52(7):459-471. PubMed ID: 28544042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, Isolation, and Structural Characterization of Novel Forced Degradation Products of Darunavir Using Advanced Analytical Techniques Like UPLC-MS, Prep-HPLC, HRMS, NMR, and FT-IR Spectroscopy.
    Modini AK; Ranga M; Puppala U; Kaliyapermal M; Geereddy MKR; Samineni R; Grover P; Konidala SK
    Chromatographia; 2023; 86(1):63-78. PubMed ID: 36531783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of major degradation products of Eprinomectin drug substance including degradation pathways using LC-HRMS and NMR.
    Adhikari S; Rustum AM
    J Pharm Biomed Anal; 2022 Jun; 215():114767. PubMed ID: 35447491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
    Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
    J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
    Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
    J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, characterization and in silico ADMET prediction of Roflumilast degradation products.
    Pinheiro MS; Viana GM; Vieira BA; de Souza AM; Rodrigues CR; Marins RC; Cabral LM; de Sousa VP
    J Pharm Biomed Anal; 2017 May; 138():126-133. PubMed ID: 28196344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of degradation products of celiprolol hydrochloride using hyphenated mass and NMR techniques.
    Sahu A; Balhara A; Raju N; Kumar BK; Sharma P; Singh DK; Singh S
    J Pharm Biomed Anal; 2021 Apr; 197():113953. PubMed ID: 33618130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
    Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
    J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structural characterization of hydrolytic degradation products of alvimopan by LC/QTOF/MS/MS and NMR studies.
    Baira SM; R S; Talluri MVNK
    J Pharm Biomed Anal; 2019 Feb; 165():399-409. PubMed ID: 30590338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
    Prajapati KJ; Kothari CS
    Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural identification of degradants of moexipril by LC-MS/MS.
    Challa PR; K R; K M V NR
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28493358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of stress degradation products of febuxostat employing ultra-performance liquid chromatography-ultraviolet/photodiode array and liquid chromatography-mass spectrometry/time-of-flight studies.
    Saha M; Bali A; Patra SR; Singh J
    Rapid Commun Mass Spectrom; 2023 Jan; 37(2):e9423. PubMed ID: 36278931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of forced degradation products of 5-hydroxymethyl-2-furaldehyde (5-HMF) by HPLC, LC-LTQ/Orbitrap and NMR studies.
    Lu Y; Guo Y; Zhang Y; Sun H; Wu X
    J Pharm Biomed Anal; 2023 Sep; 233():115470. PubMed ID: 37210891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification, isolation and characterization of dolutegravir forced degradation products and their cytotoxicity potential.
    Saida SJ; Manikandan A; Kaliyaperumal M; Rumalla CS; Khan AA; Jayaraman VB; Yanaka R; Venkat Rao S
    J Pharm Biomed Anal; 2019 Sep; 174():588-594. PubMed ID: 31261040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.